logo
‘We will miss a sister, not a collector'

‘We will miss a sister, not a collector'

Time of India6 hours ago

Transgender people thanked the collector with tears, acknowledging the support she had offered to them.
NAMAKKAL: Namakkal district collector S Uma, who has been transferred to Chennai, was given an emotional farewell by transgender people on Tuesday evening. The occasion was a special camp for transgender people organised by the
Tamil Nadu
State Rural Urban Livelihood Movement and the social welfare - women's rights department.
Transgender people expressed their gratitude to the collector for being with them in their need. "We will miss a sister, rather than just a collector," said Anusuya, a transgender person.
Anusuya said they had not met such a humble collector in recent years. "The collector fulfilled whatever help we sought from her," she added. Instead of sitting in an air-conditioned office, the collector was busy with fieldwork, she said.
You Can Also Check:
Chennai AQI
|
Weather in Chennai
|
Bank Holidays in Chennai
|
Public Holidays in Chennai
Uma assumed office as the Namakkal district collector on May 22, 2023. Now, she has been transferred as the additional secretary to the deputy chief minister to oversee the special schemes implementation department.
Adi dravidar and tribal welfare minister Dr M Mathivendhan, Rajya Sabha member KRN
Rajesh Kumar
, Namakkal MP Matheswaran, officials, transgender people and others were present.
Transgender people thanked the collector with tears, acknowledging the support she had offered to them.
When they anointed her with holy water and viboothi, Uma became emotional, unable to hold back her tears. She told them, "Call me whenever you (transgender individuals) need any help."
Uma is the first govt doctor in Tamil Nadu to be promoted to an IAS officer under the special category. Uma had served as the Chennai war room supervisor at the state level throughout the Covid-19 pandemic and played a crucial role in the Tamil Nadu govt's efforts to contain the spread of the coronavirus.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA expands warning about rare heart side effect in two leading Covid vaccines
FDA expands warning about rare heart side effect in two leading Covid vaccines

Mint

time2 hours ago

  • Mint

FDA expands warning about rare heart side effect in two leading Covid vaccines

The Food and Drug Administration has mandated that Pfizer and Moderna expand warning labels on their mRNA COVID-19 vaccines (Comirnaty and Spikevax) to highlight a rare risk of myocarditis and pericarditis, which are heart inflammation conditions, primarily in males aged 16–25. The updated labels now cite an incidence rate of 38 cases per million doses in this demographic, up from prior warnings focused on ages 12–17 (Pfizer) and 18–24 (Moderna). For all recipients under 65, the overall risk remains low at nearly 8 cases per million doses. This move follows FDA analysis of 2023–2024 vaccine safety data, including insurance claims and a study showing persistent cardiac MRI abnormalities in some patients five months post-diagnosis. The CDC, however, maintains that such cases are rare, typically resolve quickly, and are less severe than those caused by COVID-19 infection itself. Policy clash and political tensions underpin new warnings The FDA's decision conflicts with prior CDC assessments that found no increased myocarditis risk in vaccine injury databases since 2022. It also aligns with broader efforts by Health Secretary Robert F. Kennedy Jr.'s administration to tighten vaccine oversight. Kennedy recently replaced all 17 CDC advisory panel members with appointees, including anti-vaccine advocates, and FDA Commissioner Marty Makary, a critic of COVID-19 booster mandates, has restricted annual shots to high-risk groups (e.g., senior citizens). Also Read | Nestle says it will remove artificial dyes from US foods by 2026 Critics argue the label expansion overlooks context: Studies confirm COVID-19 infection poses a 16-fold higher myocarditis risk than vaccination, and most post-vaccine cases are mild, resolving with anti-inflammatory treatment. Yale researchers note the inflammation is transient, not autoimmune, allowing full recovery. Expert backlash and global safety perspectives Medical experts condemn the FDA's approach as misleading. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris of the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk," according to a report by AP.

3 Covid deaths, 30 new cases in Maha
3 Covid deaths, 30 new cases in Maha

Time of India

time5 hours ago

  • Time of India

3 Covid deaths, 30 new cases in Maha

Mumbai: Maharashtra recorded 30 new cases of COVID-19 on Wednesday and three deaths, including one in Satara and two in Nagpur, according to the state health department. Since January 1, the state has logged 2,425 cases of the infection and 36 fatalities caused by coronavirus, said officials. Of the new cases in Maharashtra, eight are from Mumbai, three from the jurisdiction of the Thane Municipal Corporation (TMC), two each from areas under the civic bodies of Navi Mumbai and Kalyan-Dombivali, eight from Pune, five from Nagpur and one each from Kolhapur and Sangli, according to an official statement. Mumbai alone has reported 973 cases of the virus, including 532 in June, since the start of January. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai It said that 35 of the 36 people who succumbed to the viral infection since the beginning of this year had co-morbidities which is a medical condition that coexist alongside a primary diagnosis. The department has conducted 27,394 COVID-19 tests across the state so far this year, while 2,166 patients have recovered to

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store